A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine
| Autor: | Tamae Hamaki, Yasuhiro Mizuno, Keisuke Takano, Morihito Takita, Toshihiko Suzuki, Takahisa Mashiba, Masahiro Kami, Kana Yamamoto, Eiji Kusumi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Pediatrics
medicine.medical_specialty Exacerbation Graves' disease Immunology heart failure Case Report vaccine Drug Discovery Pandemic medicine Pharmacology (medical) Subclinical infection Pharmacology business.industry SARS-CoV-2 COVID-19 Atrial fibrillation medicine.disease vaccination Vaccination Infectious Diseases Heart failure Medicine subclinical hyperthyroidism Complication business Graves’ disease |
| Zdroj: | Vaccines, Vol 9, Iss 1108, p 1108 (2021) Vaccines |
| Popis: | COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|